This study is the first to indicate that SPP1 can be utilized as a gene target for enhancing radiotherapy sensitivity of gastric adenocarcinoma, triggering the Wnt/β-catenin pathway. This evidence concerns the gene SPP1 and gastric adenocarcinoma.